LICENSE TO. Digital LAVA- Cinax hereby grants to Digital LAVA the non-exclusive, non-transferable worldwide right and license of renewable term to:
LICENSE TO. CENTOCOR -------------------------------
LICENSE TO. [****]*. [****]*.
LICENSE TO. [*]. ClearCommerce hereby grants to HP, under ClearCommerce's intellectual property rights, a [*] license to [*], if any, and to [*] in connection with HP's marketing and support of the Program and training with respect to the Program. Such license will include the right of HP to [*].
LICENSE TO. [ * ] The parties agree that within a reasonable period of time after the Effective Date not to exceed ninety (90) days, they shall commence good faith negotiations for Microsoft to grant the Company a non-exclusive, perpetual, royalty free license to distribute copies of the Microsoft [ * ] which is described in Exhibit C attached hereto, to end users of the Company's development tool products.
LICENSE TO. [**]: Censa hereby grants to Shiratori a non-exclusive license to make, use, and sell products solely in Japan which would otherwise infringe claims directed to [**]. In consideration for the license grant by Censa, Shiratori shall reimburse Censa for [**]% of the cost associated with filing, prosecution and maintenance of claims directed to [**]. The non-exclusive license by Censa to Shiratori shall terminate immediately upon any Shiratori breach or termination of the License Agreement and/or this Amendment.
LICENSE TO. Conduit grants to Microsoft a limited, nonexclusive and non-sublicensable license in the Territory to display the content and applications included by Conduit in the Conduit Layer to End Users during the Term.
LICENSE TO. DexCom hereby grants to Verily a [***] license under (i) any [***] jointly developed by the Parties or solely developed by Verily, solely for use outside of [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS AND ASTERISKS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED INFORMATION. EXECUTION COPY the [***] and (ii) any [***] solely developed by DexCom in subject matter consisting of [***], in each case under (i) and (ii) solely for use [***].
LICENSE TO. [*] SERVICE
LICENSE TO. SPL 16 4.1.1 Compounds and Products 16 4.1.2 Collaboration Target-Specific Technology 17 4.2 SUBLICENSES 17 4.3 DIRECT AFFILIATE LICENSES 17 4.4 COLLABORATION PLATFORM TECHNOLOGY 17 4.5 THIRD PARTY RIGHTS 17 4.5.1 Pharmacopeia Third Party Activities 17 4.5.2 No Liability 18 4.5.3 Pharmacopeia Reports to SPL On Third Party Rights 18 4.6 COLUMBIA SUBLICENSE 18 4.7 COLLABORATION RESEARCH ACTIVITIES 18
